-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612.P1.33 612. Acute Lymphoblastic Leukemia: Clinical Studies: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
ALL, Biological, Leukemia, therapy sequence, Diseases, neurotoxicity, CAR-Ts, Combinations, Hodgkin Lymphoma, Therapies, Adverse Events, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, DLBCL, T-Cell Lymphoma, Technology and Procedures, Young Adult, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant, genetic profiling, imaging, mass cytometry
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Mingzhi Zhang, MD1*, Xiaorui Fu, M.D., Ph.D1*, Huimin Meng2*, Dan Chen2*, Min Wang3,4*, Lei Zhang1*, Ling Li1*, Xin Li1*, Xinhua Wang1*, Zhenchang Sun1*, Hui Yu1*, Zhaoming Li1*, Feifei Nan1*, Yu Chang1*, Zhiyuan Zhou1*, Jiaqin Yan1*, Jiwei Li1*, Xiaolong Wu1*, Yu Wang4*, Fengtao You3*, Yinyan Wang3*, Shufen Xiang3*, Yu-Sheng Chen4*, Guifang Pan4*, Hanying Xu4*, Bozhen Zhang3,4* and Lin Yang, PhD2,3,4

1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China
3PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, China
4PersonGen-Anke Cellular Therapeutics Co., Ltd., Hefei, China

Gabriele Escherich, MD1,2*, Udo Zur Stadt, PhD3*, Dagmar Dilloo, MD4, Joerg Faber, MD, PhD5*, Tobias Feuchtinger, MD6, Thomas Imscheiler, MD7*, Norbert Jorch, MD8*, Arnulf Pekrun9*, Irene Schmid, MD10*, Martin Zimmermann, PhD11* and Martin A. Horstmann, MD12

1Clinic of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Eppendorf, Germany
2COALL - German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia, Hamburg, Germany
3Clinic of Paediatric Haematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
4University Clinic Bonn, Bonn, DEU
5Center for Pediatrics, Pediatric Hematology/Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
6Dr. Von Hauner University Children's Hospital, LMU, Munich, Germany
7Department of pediatric hematology and oncology, Helios Klinikum Krefeld, Krefeld, Germany
8Dept. Pediatrics, Evangelisches Klinikum Bethel, Bielefeld, Germany
9Klinikum Bremen Mitte, Bremen, DEU
10Division of Pediatric Hematology and Oncology, Dr. von Hauner Children´s Hospital, Ludwig Maximilian University, Munich, Germany
11Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
12University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Lori Muffly, MD, MS1, Vandana Sundaram, MPH2*, Connie Chen3*, Ilana Yurkiewicz, MD, BS4, Eric Kuo5*, Sarah Burnash3*, Jay Y. Spiegel, MD, FRCPC3, Kelly Chyan3*, Sally Arai, MD, MS3, Matthew J. Frank, MD, PhD3, Laura J. Johnston, MD3, Robert Lowsky, MD, FRCP3, Everett H Meyer, MD, PhD3*, Robert S. Negrin, MD3, Andrew R. Rezvani, MD3, Surbhi Sidana, MD6, Parveen Shiraz, MD3, Judith A Shizuru, MD, PhD7, Wen-Kai Weng, MD, PhD3, Michaela Liedtke, MD8, Hyma T. Vempaty, MD9 and David B. Miklos, MD, PhD3

1Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA
2Quantitative Sciences Unit/Medicine, Stanford University, Palo Alto, CA
3Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
4Division of Hematology/Oncology, Stanford University, Palo Alto, CA
5Department of Medicine, Stanford University, Stanford, CA
6Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA
7Stanford Univ. Med. Ctr., Stanford, CA
8Division of Hematology, Stanford University, Stanford, CA
9Kaiser Permanente, Santa Clara, CA

Michael W Boyer, MD1, Sonali Chaudhury, MBBS, MD2*, Kara L Davis, DO3, Timothy Alan Driscoll, MD4*, Stephan A Grupp, MD, PhD5, Michelle Hermiston, MD, PhD6, Samuel John, MD7*, Amy K Keating, MD, PhD8*, Christina Kovacs, BS, JD9*, Andrea Magley, BS9*, Gary Douglas Myers, MD10*, Christine L Phillips, MD11, Michael A Pulsipher, MD12, Das Purkayastha, PhD9*, Julie-An Talano, MD13 and Jennifer Willert, MD9*

1University of Utah School of Medicine, Salt Lake City, UT
2Northwestern University Feinberg School of Medicine, Chicago, IL
3Division of Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
4Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC
5Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Pediatrics (Pediatric Hematology/Oncology), University of California San Francisco, San Francisco, CA
7Division of Pediatric Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX
8Children's Hospital Colorado and University of Colorado, Aurora, CO
9Novartis Pharmaceuticals Corporation, East Hanover, NJ
10Children's Mercy Hospital, Kansas City, MO
11University of Cincinnati College of Medicine, Cincinnati, OH
12Children’s Hospital Los Angeles Cancer and Blood Disease Institute, Los Angeles, CA
13Medical College of Wisconsin, Milwaukee, WI

Franco Locatelli, MD, PhD1, Gerhard Zugmaier2, Noemi Mergen, MD3*, Peter Bader, MD4, Sima Jeha, MD5, Paul-Gerhardt Schlegel6, Jean-Pierre Bourquin, MD, PhD7, Rupert Handgretinger, MD8, Benoit Brethon, MD9*, Claudia Rössig10*, William Kormany, MD11*, Puneeth Viswagnachar12* and Christiane Chen-Santel13,14*

1Department of Pediatric Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
2Amgen Research (Munich) GmbH, Munchen, Germany
3Amgen Research (Munich), Munich, Germany
4Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6University Children's Hospital Wuerzburg, Wuerzburg, Germany
7Universitaets-Kinderspital Zurich, Zurich, Switzerland
8Hematology / Oncology, Children's University Hospital, Tubingen, Germany
9Department of Pediatric Hematology and Immunology, Robert-Debré Hospital, AP-HP, University of Paris, Paris, France
10University Children's Hospital Münster, Münster, Germany
11Global Patient Safety, Amgen Inc, Thousand Oaks, CA
12Biostatistical Sciences, IQVIA, Bangalore, India
13Charité University Medicine Berlin, Berlin, Germany
14Department of Pediatrics, University Medical Centre, Rostock, Rostock, Germany

Trisha Larkin, MD/MBA1,2*, Abdelrahman H Elsayed, MSc3, Roya Rafiee, M.Sc., Ph.D.4, Natasha Emanuel5*, Beate Greer6*, Biljana N. Horn, MD7 and Jatinder K Lamba, MSc, PhD3

1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
2Department of Pediatrics, University of Florida, Gainesville, FL
3Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL
4Department of Pharmacotherapy and Translational Research, University of Florida, College of Pharmacy, Gainesville, FL
5Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
6College of Medicine, University of Florida, Gainesville, FL
7UF Shand's Children Hospital, University of Florida, Gainesville, FL

Agne Taraseviciute, MD1*, Deepa Bhojwani, MD2, Ravi Bansal, PhD3*, Bradley S Peterson, MD4*, Michael A Pulsipher, MD5, Alan S. Wayne, MD6, Courtney Allem7*, Michael Sheard, PhD8* and Joey Trampush, PhD9*

1Cancer and Blood Disease Institute, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
2Division of Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC, Los Angeles, CA
3Department of Pediatrics, Children's Hospital Los Angeles, Institute for the Developing Mind, The Saban Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA
4Division of Child and Adolescent Psychiatry, Department of Pediatrics, Children's Hospital Los Angeles, Institute of the Developing Mind, The Saban Research Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA
5Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
6Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
7Children's Hospital Los Angeles, Institute for the Developing Mind, The Saban Research Institute, Los Angeles, CA
8Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
9Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, CA

Momoko Nakamura1*, Yasuyuki Arai, MD, PhD1, Shigeki Hirabayashi2*, Tadakazu Kondo, MD, PhD2, Noriko Doki, MD, PhD3*, Naoyuki Uchida, MD, PhD4, Takahiro Fukuda5*, Yukiyasu Ozawa, MD, PhD6*, Masatsugu Tanaka, MD7*, Makoto Onizuka, MD, PhD8, Tatsuo Ichinohe9, Yoshiko Atsuta, MD, PhD10* and Shinichi Kako, MD11

1Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, KYO, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
4Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
5Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
6Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
7Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
8Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
9Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
10Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
11Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

Ashley Ikwuezunma, BS1*, Ankhi Dutta, MD, MPH2*, Maria Isabel Castellanos, MD3, Hana Paek, PharmD2*, Debra Palazzi, MD, MEd2*, Karen R Rabin, MD, PhD4, Michael E. Scheurer, PhD, MPH5* and Maria Monica Monica Gramatges, MD, PhD6,7

1University of Texas Rio Grande Valley School of Medicine, Edinburg, TX
2Texas Children's Hospital at Baylor College of Medicine, Houston, TX
3Texas Children's Cancer and Hematology Centers, Texas Children's Hospital at Baylor College of Medicine, Houston, TX
4Baylor College of Medicine TX Children's Cancer Center, Houston, TX
5Texas Children's Hospital, Houston, TX
6Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX
7Pediatric Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX

Danielle Fredman1*, Yulia Volchek, MD2*, Gabriel Heering1*, Keren Shichrur, PhD3*, Ronit Yerushalmi, MD2, Noga Shem-Tov, MD4*, Elena Ribakovsky, MD2*, Avichai Shimoni, MD5*, Abraham Avigdor, MD6, Arnon Nagler, MD7 and Jonathan Canaani, MD8

1Chaim Sheba Medical Center, Tel Hashomer, Israel
2Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
3Molecular Oncology, Felsenstein Medical Research Center, Petah Tikva, Israel
4Division of Hematology and Bone Marrow Transplantation,, Chaim Sheba Medical Center, Ramat-Gan, Israel
5Division of Hematology, Sheba Medical Center, Ramat Gan, Israel
6Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
7Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel
8Hematology Division, Sheba Medical Center, Givatayim, Israel

Mayada Abu Shanap, MD1*, Iyad Sultan, MD2*, Amal Abu-Ghosh, MD3*, Hasan Hashem, MD4*, Abdelghani Tbakhi, MD5* and Rawad Rihani, MBBS, MD2*

1Pediatric Department, King Hussein Cancer center (KHCC), Amman, Amman, Jordan
2Pediatric Department, King Hussein Cancer center (KHCC), Amman, Jordan
3Pediatric Department, King Hussein Cancer Center, Amman, DC, Jordan
4Department of Pediatrics, King Hussein Cancer Center, Amman, OH, Jordan
5Department of Cell Therapy and Applied Genomics, King Hussein Cancer Center, Amman, Jordan

Josep-Maria Ribera1, Olga García1*, Pau Montesinos, MD, PhD2*, Pilar Martinez, MD3*, Jordi Esteve, MD, PhD4, Daniel Esteban5*, María José Moreno, MD6*, Natalia Alonso7*, José González-Campos, MD8*, Arancha Bermúdez, MD9*, Anna Torrent1*, Joaquin Martinez-Lopez, MD10*, Santiago Mercadal, MD11* and Ramon Garcia-Sanz12

1Hematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
2Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
3Haematology department, 12 Octubre Hospital, Madrid, Spain
4Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
5Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
6Haematology department, Virgen de la victoria Hospital, Malaga, Spain
7Complejo Hospitalario Universitario. Santiago de Compostela, Santiago de Compostela, Spain
8Hematology Department, Hospital Universitario Virgen del Rocio. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla, Sevilla, Spain
9Hematology Department, University Hospital "Marqués de Valdecilla", Santander, Spain
10Hematology and hemotherapy department, Hospital Universitario 12 De Octubre, Madrid, Spain
11ICO-Hospital Duran i Reynals, Hospitalet De Llobregat, Spain
12Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

*signifies non-member of ASH